
Wuhan Rocgene Biomedical Technology Co., Ltd., located at No. 378 Gaoxin Second Road, East Lake High-Tech Development Zone, Wuhan, Hubei Province, held its grand opening ceremony on January 21, 2024.

As an enterprise focused on research, testing and development, the opening of Wuhan Rocgene Biomedical Technology Co., Ltd. marks another solid step for Optics Valley Bio-City in the field of biotechnology.

☆☆☆☆☆
Opening Ceremony

At the opening ceremony, Mr. Dai Tao, Deputy General Manager of Rocgene (Beijing) Technology Co., Ltd., delivered a warm speech on behalf of General Manager Guo Qiuzhen. He stated that the establishment of Wuhan Rocgene Biomedical Technology Co., Ltd. is an important achievement of innovative development in the biotechnology sector and a vivid example of Optics Valley Bio-City’s continuous promotion of industrial upgrading. He expressed hope that Wuhan Rocgene will leverage its strengths to make greater contributions to the development of China’s biotechnology industry.

Subsequently, Ms. Yu Yanfei, Director of the Industry Department of the Construction Service Center of Wuhan National Bio-Industrial Base, delivered a speech. She noted that as a key base for China’s biotechnology industry, Optics Valley Bio-City has long been committed to promoting industrial innovation and development. Rocgene has long focused on translating cutting-edge life science technologies into clinically relevant medical research products and developing molecular products with independent intellectual property rights. She expressed confidence that Rocgene’s presence will further enhance the competitiveness and influence of Optics Valley Bio-City in the molecular diagnostics market. She hoped that while achieving its own development, Rocgene will deepen cooperation with other enterprises in the park to jointly drive the growth of the biological industry in Optics Valley. She wished Rocgene a soaring future!

Mr. Zhao Xiangyang from Refody Biomedical (Shanghai) Co., Ltd. also delivered a speech. He stated that the cooperation between Refody and Wuhan Rocgene is not only a strong alliance but also a concrete practice to realize the Chinese Dream of Health. The two parties will jointly develop innovative technologies, promote the upgrading of biomedical equipment and solutions, and contribute to human health.

Finally, Mr. Shi Taiping, General Manager of Wuhan Rocgene Biomedical Technology Co., Ltd., expressed sincere gratitude to all guests. He shared three key words with the attendees: The first was “Gratitude”, thanking Ms. Yu Yanfei for her support in site selection, planning and policies; thanking leaders of Rocgene for their guidance; and thanking the preparation team for their hard work. The second was “Vision”, stating that developing high-end medical devices made in China is the aspiration and vision of Rocgene people. The national 14th Five-Year Plan clearly calls for accelerating the localization of high-end medical devices, and Rocgene is honored to participate in and witness this process. The third was “Value”, expressing hope to deepen cooperation with partners, take root in Optics Valley Bio-City, realize personal value, and help the medical device park demonstrate its value. Together, they will build Optics Valley into a world-class hub. Under joint efforts, today marks the start of a new journey, the continuation of vision, and the first step toward value creation.

On-site Tour
After the ceremony, company leaders and guests visited the laboratory together. As the core area of Wuhan Rocgene Biomedical Technology Co., Ltd., the laboratory concentrates the company’s R&D and technical strength. During the visit, researchers introduced upcoming research projects covering multiple directions in biomedicine, aimed at making greater contributions to human health. Leaders and guests spoke highly of the company’s research work and expected more breakthroughs and innovations in its future development.




In summary, the opening ceremony of Wuhan Rocgene Biomedical Technology Co., Ltd. was a grand event and an important milestone in the development of Optics Valley Bio-City in biotechnology. We believe that with joint efforts from all parties, Optics Valley Bio-City will achieve more brilliant results in the future and make greater contributions to the development of China’s biotechnology industry.
06
16
08
18

